Epidemiological, clinical, and therapeutic characteristics of Behçet's disease: a monocentric study in Tunisia

Introduction to describe the epidemiological, clinical, therapeutic and evolving characteristics of Behçet´s disease and identify prognostic factors. Methods we have realized a retrospective, single-center study, conducted over a period of 26 years and including 130 patients presenting Behçet´s disease and hospitalized in an Internal Medicine Department. Results the mean age of the Behçet´s disease at onset was 30.3 ±8.8 years and that at diagnosis was 34.6 ±9.4 years. The sex ratio (male/female) was 2.5. The mean delay of diagnosis was 53.5 months. Oral aphthosis was constant. The frequency of the manifestations was: genital aphtosis 71.5%, pseudofolliculitis 84.6%, erythema nodosum 11.5%, positive pathergy test 50%, ocular disease 36.9%, venous thrombosis 30%, arterial disease 4.6%, joint damage 30.8%, neurological disease 19.2% and digestive disease 0.8%. The male gender was significantly associated with ocular involvement (p =0.02), venous disease (p =0.01) and occurrence of relapses (p =0.01). The mean follow up was 68.5 ± 77.3 months. The poor survival prognostic factors were male gender, ocular involvement, venous disease, cardiovascular disease, a duration of follow up ≤12 months and a diagnostic delay ≤ 24 months. Conclusion: improving the prognosis of Behçet´s disease requires a shortening of the time to diagnosis, multidisciplinary collaboration, intensive treatment of functional threats, regular monitoring, and patient adherence.

[1]  S. Hamzaoui,et al.  Les manifestations dermatologiques de la maladie de Behçet , 2015 .

[2]  L. Essaadouni,et al.  L’oculoBehçet : fréquence, caractéristiques, corrélations et facteurs prédictifs de cécité , 2014 .

[3]  G. Kalkan,et al.  Demographic and clinical features of 521 Turkish patients with Behçet's disease , 2014, International journal of dermatology.

[4]  P. Cacoub,et al.  [Treatment of Behçet's disease]. , 2014, La Revue de medecine interne.

[5]  Queiroz,et al.  The International Criteria for Behçet's Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria , 2014, Journal of the European Academy of Dermatology and Venereology : JEADV.

[6]  J. Piette,et al.  Spectrum of Cardiac Lesions in Behçet Disease: A Series of 52 Patients and Review of the Literature , 2012, Medicine.

[7]  M. Jira,et al.  [Behcet syndrome: thirty comments with lung and vascular injury of peripheral vessels]. , 2012, Presse medicale.

[8]  M. Bértolo,et al.  Behçet’s disease in Brazilian patients: demographic and clinical features , 2012, Rheumatology International.

[9]  T. Amezyane,et al.  Maladie de Behçet : aspects épidémiologiques et cliniques à propos de 200 cas , 2011 .

[10]  Y. Ishigatsubo,et al.  Behçet Disease: Evolution of Clinical Manifestations , 2011, Medicine.

[11]  F. Shahram,et al.  Behcet’s disease in Iran: analysis of 6500 cases , 2010, International journal of rheumatic diseases.

[12]  D. Kidd,et al.  Neuro-Behçet's disease: epidemiology, clinical characteristics, and management , 2009, The Lancet Neurology.

[13]  A. Silman,et al.  Management of Behçet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behçet disease , 2008, Annals of the rheumatic diseases.

[14]  S. Koussa,et al.  [Neurological manifestations of Behcet's disease: 22 cases among 170 patients]. , 2009, Presse medicale.

[15]  K. Bouslama,et al.  [Behcet's disease in Maghreb: Behcet Maghreb study about 1460 cases]. , 2009, La Revue de medecine interne.

[16]  J. Coste,et al.  Population-based prevalence study of Behçet's disease: differences by ethnic origin and low variation by age at immigration. , 2008, Arthritis and rheumatism.

[17]  F. Davatchi Behcet's disease: global perspective , 2007 .

[18]  K. Bouslama,et al.  [Behçet's disease in Tunisia. Clinical study of 519 cases]. , 2006, La Revue de medecine interne.

[19]  N. Ashjazadeh,et al.  Neurological manifestations of Behçet's disease. , 2006, Saudi medical journal.

[20]  C. Zouboulis,et al.  Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. , 2003, Clinical and experimental rheumatology.

[21]  U. Tursen,et al.  Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease , 2003, International journal of dermatology.

[22]  M. Zoghi,et al.  Cardiovascular involvement in Behçet's disease. , 2002, Japanese heart journal.

[23]  H. Ben Maïz,et al.  [Neurological manifestations in Behcet's disease. Forty observations in a cohort of 300 patients]. , 2002, Journal des maladies vasculaires.

[24]  G. Akman-Demir,et al.  Clinical patterns of neurological involvement in Behçet's disease: evaluation of 200 patients. The Neuro-Behçet Study Group. , 1999, Brain : a journal of neurology.